ArticleACS infectious diseases2019

Repurposing Eukaryotic Kinase Inhibitors as Colistin Adjuvants in Gram-Negative Bacteria.

William T Barker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.